TrialBritish journal of cancer2019

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.

Jean-Yves Blay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.